Bayobay, Khalil Kent .

HRN: 21-83-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
AMPICILLIN 500MG (VIAL)
12/14/2022
12/20/2022
IVT
150 Mg
Q6
Acute Tonsillopharyngitis Urti
Waiting Final Action 
12/15/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
12/15/2022
12/17/2022
PO
1.5 Ml
OD
ATP, URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: